Self-monitoring of blood glucose levels in patients with type 2 diabetes mellitus not taking insulin: A meta-analysis

American Journal of Managed Care

Volumn 14, Issue 7, 2008, Pages 468-475

  Towfigh, Ali ^a   Romanova, Maria ^a   Weinreb, Jane E ^a   Munjas, Brett ^a   Suttorp, Marika J ^b   Zhou, Annie ^b   Shekelle, Paul G ^a,b  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b RAND CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; AMYLIN DERIVATIVE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; REPAGLINIDE; SULFONYLUREA;

BODY MASS; BODY WEIGHT; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIABETES CONTROL; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; META ANALYSIS; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT EDUCATION; PRIORITY JOURNAL; REVIEW; SELF CARE; SELF MONITORING; SYSTEMATIC REVIEW; WEIGHT REDUCTION;

BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 47749083574     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. World Health Organization. Media centre: diabetes. September 2006. http://www.who.int/mediacentre/factsheets/fs312/en/index.html. Accessed May 2, 2001.
2. National Diabetes Information Clearinghouse (NDIC). National diabetes statistics. November 2005. http://diabetes.niddk.nih.gov/dm/pubs/ statistics/index.htm#14. Accessed May 2, 2007.
3. Fontbonne A, Billault B, Acosta M, et al. Is glucose self-monitoring beneficial in non-insulin-treated diabetic patients? Results of a randomized comparative trial. Diabetes Metab. 1989;15(5):255-260.
4. Guerci B, Drouin P, Grange V, et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab. 2003;29(6):587-594.
5. Schwedes U, Siebolds M, Mertes G. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care. 2002;25(11):1928-1932.
6. Wing RR, Epstein LH, Nowalk MP, Scott N, Koeske R, Hagg S. Does self-monitoring of blood glucose levels improve dietary compliance for obese patients with type II diabetes? Am J Med. 1986;81(5):830-836.
7. Rutten G, van Eijk J, de Nobel E, Beek M, van der Velden H. Feasibility and effects of a diabetes type II protocol with blood glucose self-monitoring in general practice. Fam Pract. 1990;7(4):273-278.
8. Muchmore DB, Springer J, Miller M. Self-monitoring of blood glucose in overweight type 2 diabetic patients. Acta Diabetol. 1994;31(4):215-219.
9. Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother. 1996;30(3):238-243.
10. Kibriya MG, Ali L, Banik NG, Khan AK. Home monitoring of blood glucose (HMBG) in type-2 diabetes mellitus in a developing country. Diabetes Res Clin Pract. 1999;46(3):253-257.
11. Jansen JP. Self-monitoring of glucose in type 2 diabetes mellitus: a Bayesian meta-analysis of direct and indirect comparisons. Curr Med Res Opin. 2006;22(4):671-681.
12. Welschen LM, Bloemendal E, Nijpels G, et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care. 2005;28(6):1510-1517.
13. Balk E, Teplinsky E, Trikalinos T, et al. Applicability of the evidence regarding intensive glycemic control and self-monitored blood glucose to Medicare patients with type 2 diabetes. Technology Assessment Report. September 7, 2007. http://www.cms.hhs.gov/determinationprocess/downloads/id40TA. pdf. Accessed March 12, 2008.
14. Davidson MB, Castellanos M, Kain D, Duran P. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med. 2005;118(4):422-425.
15. Davidson MB. Counterpoint: self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money. Diabetes Care. 2005;28(6):1531-1533.
16. Coster S, Gulliford MC, Seed PT, Powrie JK, Swaminathan R. Self-monitoring in type 2 diabetes mellitus: a meta-analysis. Diabet Med. 2000;17(11):755-761.
17. Faas A, Schellevis FG, Van Eijk JT. The efficacy of self-monitoring of blood glucose in NIDDM subjects: a criteria-based literature review. Diabetes Care. 1997;20(9):1482-1486.
18. Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol. 2006;59(1):7-10.
19. Verhagen AP, de Vet HC, de Bie RA, et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol. 1998;51(12):1235-1241.
20. Ray JW, Shadish WR. How interchangeable are different estimators of effect size [published correction appears in J Consult Clin Psychol. 1998;66(3):532]. J Consult Clin Psychol. 1996;64(6):1316-1325.
21. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188.
22. Berkey CS, Hoaglin DC, Mosteller F, Colditz GA. A random-effects regression model for meta-analysis. Stat Med. 1995;14(4):395-411.
23. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560.
24. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088-1101.
25. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634.
26. StataCorp LP. STATA Statistical Software: Release 9. College Station, TX: StataCorp LP; 2005.
27. Farmer A, Wade A, Goyder E, et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ. 2007;335(7611):132-140.
28. Moher D, Pham B, Jones A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet. 1998;352(9128):609-613.
29. Allen BT, DeLong ER, Feussner JR. Impact of glucose self-monitoring on non-insulin-treated patients with type Il diabetes mellitus. Randomized controlled trial comparing blood and urine testing. Diabetes Care. 1990;13(10):1044-1050.
30. Tunis SL, Minshall ME. Self-monitoring of blood glucose in type 2 diabetes: cost-effectiveness in the United States. Am J Manag Care. 2008;14(3):131-140.
31. Bolen S, Feldman L, Vassy J, et al. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus [published correction appears in Ann Intern Med. 2007;147(12):887]. Ann Intern Med. 2007;147(6):386-399.
32. Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care. 2002;25(7):1159-1171.